Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Otol Neurotol. 2011 Sep;32(7):1094-101. doi: 10.1097/MAO.0b013e31822a97f4.

    Envelope versus fine structure speech coding strategy: a crossover study.

    Source

    Department of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria.

    Abstract

    OBJECTIVE:

    The transmission of fine structure information to cochlear implant users is an expanding area of research. Previous studies comparing the fine structure processing (FSP) speech coding strategy to the envelope-based continuous interleaved sampling (CIS) strategy indicated improved speech perception when using the fine structure strategy. Those investigations were performed with an extended frequency spectrum in the low frequencies together with the fine structure strategy. The current study addresses the question whether these improvements are due to the presentation of fine structure per se or rather the extended frequency spectrum. Hence, this cross over study compares the two strategies using an identical frequency spectrum.

    STUDY DESIGN:

    Randomized crossover study.

    PATIENTS:

    31 patients were randomly assigned to two groups.

    INTERVENTIONS:

    One group was fitted with a CIS map for 4 weeks, tested and subsequently fitted with a FSP map for 4 weeks. The other group followed the same pattern in reverse.

    MAIN OUTCOME MEASURES:

    Test material consisted of sentence tests in noise, monosyllables in quiet and melody recognition.

    RESULTS:

    No statistical significance was noted between the different speech coding strategies at an identical frequency spectrum.

    CONCLUSION:

    This study shows that there is no difference in speech perception with FSP compared to CIS at an extended frequency spectrum. Therefore, the extended frequency spectrum in the low frequencies might explain a benefit of FSP observed in previous studies.

    PMID:
    21817932
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Lippincott Williams & Wilkins

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk